Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

SR-147778: further evidence that CB1 antagonism may be effective for the treatment of alcoholism

Feb. 8, 2005

New varenicline formulations for smoking cessation reported by Pfizer

Feb. 4, 2005

GDNF shows promise as a novel target for treating alcohol abuse

Feb. 3, 2005

NIDA grant supports drug addiction therapy development at InfleXion

Feb. 1, 2005

Phase IIa Tetrodin study completes enrollment

Jan. 20, 2005

Campral available in U.S.

Jan. 14, 2005

Vigabatrin induces abstinence in methamphetamine, cocaine addiction

Jan. 10, 2005

IND accepted for phase I study of CPP-109 for treating cocaine addition

Jan. 10, 2005

USAMRIID awards grant to Lexicon for ricin biodefense efforts

Jan. 4, 2005

Standard and novel mGluR5 antagonists in the treatment of cocaine addiction

Jan. 3, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....